Latest Insider Transactions at Treace Medical Concepts, Inc. (TMCI)
This section provides a real-time view of insider transactions for Treace Medical Concepts, Inc. (TMCI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TREACE MEDICAL CONCEPTS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TREACE MEDICAL CONCEPTS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
26,241
-2.08%
|
$656,025
$25.02 P/Share
|
|
Mar 23
2023
|
Lawrence W Hamilton |
BUY
Grant, award, or other acquisition
|
Direct |
2,753
+35.29%
|
-
|
|
Mar 15
2023
|
Thomas E Timbie Director |
SELL
Open market or private sale
|
Indirect |
50,000
-4.17%
|
$1,150,000
$23.03 P/Share
|
|
Mar 15
2023
|
Daniel E. Owens |
SELL
Open market or private sale
|
Direct |
6,250
-16.82%
|
$137,500
$22.87 P/Share
|
|
Mar 15
2023
|
Daniel E. Owens |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+14.4%
|
$43,750
$7.03 P/Share
|
|
Mar 14
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
9,400
-0.74%
|
$216,200
$23.25 P/Share
|
|
Mar 13
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
9,400
-0.37%
|
$225,600
$24.4 P/Share
|
|
Mar 10
2023
|
Scot Michael Elder Chief Legl & Comp Off, CorpSec |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+35.52%
|
-
|
|
Mar 10
2023
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,925
+41.44%
|
-
|
|
Mar 10
2023
|
Daniel E. Owens |
BUY
Grant, award, or other acquisition
|
Direct |
20,625
+40.02%
|
-
|
|
Mar 10
2023
|
Mark Hair Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,825
+38.59%
|
-
|
|
Mar 10
2023
|
Aaron Berutti SVP, Sales |
BUY
Grant, award, or other acquisition
|
Direct |
29,800
+41.02%
|
-
|
|
Mar 10
2023
|
John T. Treace Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
82,475
+1.45%
|
-
|
|
Mar 09
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
1,502
-0.14%
|
$39,052
$26.0 P/Share
|
|
Mar 09
2023
|
Scot Michael Elder Chief Legl & Comp Off, CorpSec |
SELL
Open market or private sale
|
Direct |
177
-0.78%
|
$4,248
$24.41 P/Share
|
|
Mar 09
2023
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
505
-5.06%
|
$12,120
$24.41 P/Share
|
|
Mar 09
2023
|
Daniel E. Owens |
SELL
Open market or private sale
|
Direct |
411
-3.84%
|
$9,864
$24.41 P/Share
|
|
Mar 09
2023
|
Mark Hair Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,040
-3.69%
|
$24,960
$24.41 P/Share
|
|
Mar 09
2023
|
Aaron Berutti SVP, Sales |
SELL
Open market or private sale
|
Direct |
733
-5.32%
|
$17,592
$24.41 P/Share
|
|
Mar 09
2023
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,075
-0.04%
|
$49,800
$24.41 P/Share
|
|
Mar 08
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
45,000
-2.06%
|
$1,035,000
$23.25 P/Share
|
|
Mar 01
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
50,000
-4.33%
|
$1,050,000
$21.35 P/Share
|
|
Mar 01
2023
|
James T Treace |
SELL
Open market or private sale
|
Direct |
12,684
-1.3%
|
$266,364
$21.36 P/Share
|
|
Feb 28
2023
|
James T Treace |
SELL
Open market or private sale
|
Direct |
37,316
-3.69%
|
$783,636
$21.54 P/Share
|
|
Feb 22
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
9,400
-0.73%
|
$197,400
$21.97 P/Share
|
|
Feb 21
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
9,400
-0.72%
|
$197,400
$21.74 P/Share
|
|
Feb 16
2023
|
Thomas E Timbie Director |
SELL
Bona fide gift
|
Indirect |
8,300
-2.24%
|
-
|
|
Feb 15
2023
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
25,000
-71.48%
|
$525,000
$21.69 P/Share
|
|
Feb 15
2023
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+41.68%
|
$0
$0.1 P/Share
|
|
Feb 15
2023
|
Thomas E Timbie Director |
SELL
Open market or private sale
|
Indirect |
50,000
-4.0%
|
$1,050,000
$21.71 P/Share
|
|
Feb 08
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
27,731
-2.09%
|
$582,351
$21.7 P/Share
|
|
Feb 07
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
8,800
-0.66%
|
$202,400
$23.0 P/Share
|
|
Feb 02
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
4,011
-0.35%
|
$96,264
$24.0 P/Share
|
|
Jan 31
2023
|
James T Treace |
SELL
Open market or private sale
|
Direct |
11,929
-1.17%
|
$274,367
$23.19 P/Share
|
|
Jan 30
2023
|
James T Treace |
SELL
Open market or private sale
|
Direct |
1,054
-0.1%
|
$25,296
$24.55 P/Share
|
|
Jan 30
2023
|
James T Treace |
SELL
Open market or private sale
|
Direct |
37,017
-1.76%
|
$851,391
$23.34 P/Share
|
|
Jan 30
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
90,989
-2.47%
|
$2,092,747
$23.79 P/Share
|
|
Jan 25
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
27,722
-1.02%
|
$693,050
$25.51 P/Share
|
|
Jan 24
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
25,921
-1.86%
|
$673,946
$26.03 P/Share
|
|
Jan 18
2023
|
Thomas E Timbie Director |
SELL
Open market or private sale
|
Indirect |
50,000
-3.85%
|
$1,250,000
$25.88 P/Share
|
|
Jan 17
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
11,014
-0.87%
|
$286,364
$26.0 P/Share
|
|
Jan 13
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
6,519
-0.51%
|
$169,494
$26.0 P/Share
|
|
Jan 12
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
45,536
-1.6%
|
$1,138,400
$25.54 P/Share
|
|
Jan 12
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
42,467
-3.24%
|
$1,104,142
$26.0 P/Share
|
|
Jan 12
2023
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
25,000
-71.48%
|
$625,000
$25.57 P/Share
|
|
Jan 12
2023
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+41.68%
|
$0
$0.1 P/Share
|
|
Jan 11
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
9,719
-0.67%
|
$233,256
$24.32 P/Share
|
|
Jan 09
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
10,444
-0.79%
|
$250,656
$24.0 P/Share
|
|
Jan 05
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
9,556
-0.72%
|
$229,344
$24.0 P/Share
|
|
Dec 30
2022
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
75,000
-5.34%
|
$1,650,000
$22.67 P/Share
|